SCHEMBL3386038

SCHEMBL3386038

O=C(Nc1ccc(-c2ccc3c(C(=O)O)n[nH]c3c2)cc1)c1ccnnc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 4/20 0.48
CLK2 P49760 2/20 0.48
CLK3 P49761 2/20 0.48
FGFR1 P11362 1/20 0.46
FGFR2 P21802 1/20 0.46
FGFR3 P22607 1/20 0.46
HDAC6 Q9UBN7 4/20 0.45
FLT3 P36888 4/20 0.43
AAK1 Q2M2I8 1/20 0.43
CCNA2 P20248 1/20 0.43
CDK2 P24941 1/20 0.43
CCNA1 P78396 1/20 0.43
WNT1 P04628 2/20 0.42
PRKAG1 P54619 1/20 0.41
PRKAA1 Q13131 1/20 0.41
PRKAB1 Q9Y478 1/20 0.41
ITK Q08881 4/20 0.41
JAK2 O60674 1/20 0.41
JAK1 P23458 1/20 0.41
TYK2 P29597 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3387710 0.89 FLT3 (0.51) DYRK1ACLK2CLK3FGFR1FGFR2
SCHEMBL3386660 0.85 KDM4E (0.47) DYRK1ACLK2CLK3FGFR1FGFR2
SCHEMBL3385649 0.80 NPC1 (0.50) DYRK1ACLK2CLK3WNT1
SCHEMBL3380466 0.78 PAK1 (0.47) DYRK1ACLK2CLK3WNT1PRKAG1
SCHEMBL3383253 0.77 NTRK1 (0.59) DYRK1AHDAC6FLT3ITKJAK3
SCHEMBL3385551 0.75 SGK1 (0.47) DYRK1AFGFR1FGFR2FGFR3HDAC6
SCHEMBL3386126 0.75 PTGDR2 (0.43) DYRK1AFGFR1FGFR2FGFR3HDAC6
SCHEMBL3386831 0.75 NPC1 (0.54) FLT3PRKAG1PRKAA1PRKAB1
SCHEMBL3383247 0.74 HPGD (0.53) FLT3CCNA2CDK2CCNA1PRKAG1
SCHEMBL3383259 0.74 MAPT (0.57) ITK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010064875-A2 NOVEL INDAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS PROTEIN KINASE INHIBITORS FOR PROLIFERATIVE DISEASES TREATMENT, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2010-06-10 WO claimed
WO-2010064875-A2 NOVEL INDAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS PROTEIN KINASE INHIBITORS FOR PROLIFERATIVE DISEASES TREATMENT, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2010-06-10 WO disclosed